HAESMBZCFVXSPD-RCAGDWDBSA-N
C27H27Cl2F6N3O — CID 162596269
Data last refreshed: (MolForge compound catalog, from PubChem)
About HAESMBZCFVXSPD-RCAGDWDBSA-N
HAESMBZCFVXSPD-RCAGDWDBSA-N (PubChem CID 162596269) has the molecular formula C27H27Cl2F6N3O and a molecular weight of 594.43 g/mol. Its IUPAC name is 2-(aminomethylidene)-N-[(2R)-2-(2,6-dichlorophenyl)-2-fluoroethyl]-N-[(3,5-difluorophenyl)methyl]-4,4,4-trifluoro-3-(4-methylcyclohexyl)iminobutanamide.
Molecular Properties
| Compound Name | HAESMBZCFVXSPD-RCAGDWDBSA-N |
|---|---|
| PubChem CID | 162596269 |
| Molecular Formula | C27H27Cl2F6N3O |
| Molecular Weight | 594.43 g/mol |
| Exact Mass | 593.14 |
| IUPAC Name | 2-(aminomethylidene)-N-[(2R)-2-(2,6-dichlorophenyl)-2-fluoroethyl]-N-[(3,5-difluorophenyl)methyl]-4,4,4-trifluoro-3-(4-methylcyclohexyl)iminobutanamide |
| SMILES | CC1CCC(/N=C(/C(=CN)C(=O)N(Cc2cc(F)cc(F)c2)C[C@H](F)c2c(Cl)cccc2Cl)C(F)(F)F)CC1 |
| InChI | InChI=1S/C27H27Cl2F6N3O/c1-15-5-7-19(8-6-15)37-25(27(33,34)35)20(12-36)26(39)38(13-16-9-17(30)11-18(31)10-16)14-23(32)24-21(28)3-2-4-22(24)29/h2-4,9-12,15,19,23H,5-8,13-14,36H2,1H3/b20-12?,37-25-/t15?,19?,23-/m0/s1 |
| InChIKey | COYFXLZUULEVSK-GGIIZIEKSA-N |
| XLogP | 7.74 |
| TPSA | 58.69 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 594.43 |
| LogP ≤ 5 | 7.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162596269 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.